SEC Form 4 · accession 0001209191-17-046962
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas A. Edwards
Director
Period of report
Jul 28, 2017
Accepted (ET)
Aug 1, 2017 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2017 | M | 6,767 | $0.00 | A | 138,785 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jul 28, 2017 | M | 6,767 | D | — | — | Common Stock | 6,767 | 6,767 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on July 28, 2015.
- F2Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F3The restricted stock units were awarded on July 28, 2015 and vest in three equal installments on July 28, 2016, July 28, 2017 and July 28, 2018, subject to the Reporting Person's continued service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.